"HDL metabolism and its changes in patients with the meabolic syndrome after firate therapy"@en . "2008-09-16+02:00"^^ . " fractional esterification rate" . "metabolic syndrome; fractional esterification rate; atherogenic index of plasma; fibrates; gene expression"@en . "2007-03-01+01:00"^^ . "23"^^ . "23"^^ . . . . . "Metabolismus HDL a jeho zm\u011Bny u pacient\u016F s metabolick\u00FDm syndromem p\u0159i l\u00E9\u010Db\u011B fibr\u00E1tem" . . "2007-12-31+01:00"^^ . " fibrates" . . "metabolic syndrome" . . "1"^^ . "1"^^ . . . . . . . . " atherogenic index of plasma" . "2005-01-01+01:00"^^ . "Solution of the project fulfilled annotated goals in appropriate term. Results were published with dedication to no of this project IGA MZ + other projects in journals with known IF, in a number of other journals and abstracts from conferences."@en . "0"^^ . . "\u0158e\u0161en\u00ED splnilo anotovan\u00E9 c\u00EDle ve schv\u00E1len\u00E9m term\u00EDnu. V\u00FDsledky publikov\u00E1ny s dedikac\u00ED tomuto projektu IGA MZ + dal\u0161\u00EDm grant\u016Fm, 5x origin\u00E1ln\u00ED pr\u00E1ce v \u010Dasopisech s IF, \u0159ada dal\u0161\u00EDch prac\u00ED a abstrakt z kongres\u016F."@cs . . . "In patients with metabolic syndrome lipid parametres, namely HDL partices, will be followed before and after initiation of the fibrate therapy. The risk of atherosclerosis will be estimated using new markers of atherogenesis. The molecular basis of fibrate action in dyslipidaemia accompanying metabolic syndrome will be evaluated determining the expression of genes for LCAT and CETP after fibrate therapy initiation."@en . "NR8328" . "http://www.isvav.cz/projectDetail.do?rowId=NR8328"^^ . . . "U pacient\u016F s matabolick\u00FDm syndromem budou sledov\u00E1ny lipidov\u00E9 parametry se zam\u011B\u0159en\u00EDm na HDL \u010D\u00E1stice p\u0159ed a po l\u00E9\u010Db\u011B fibr\u00E1tem a bude u nich stanovov\u00E1no aterogenn\u00ED riziko pomoc\u00ED nov\u00FDch ukazatel\u016F aterogeneze. Bude sledov\u00E1n mechanismus \u00FA\u010Dinku fibr\u00E1t\u016F u dyslipid\u00E9mie prov\u00E1zej\u00EDc\u00ED metabolick\u00FD syndrom sledov\u00E1n\u00EDm zm\u011Bn exprese gen\u016F pro LCAT a CETP." .